UNSPSC 51352300: Estrogens, progestins, or internal contraceptives, synthesized

This classification denotes Estrogens, progestins, or internal contraceptives composed of multiple constituents, with no dominant constituent.

UNSPSC 51352300 Estrogens, progestins, or internal contraceptives, synthesized is a Class code covering hormonal contraceptive medications and related synthesized pharmaceutical products procured by state and local government health systems, Medicaid agencies, and cooperative purchasing alliances. State and local buyers under this code source branded and generic formulations—tablets, patches, injections, intrauterine devices, and other delivery forms—for distribution through health department clinics, correctional facilities, public hospitals, and benefit programs serving eligible populations. The code reflects actual purchasing focused on pharmaceutical supply chain management, regulatory compliance (FDA approval, cGMP certification, Drug Supply Chain Security Act adherence), and negotiated pricing through authorized wholesale distribution channels.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (solicitation S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with responses due March 26, 2026. The RFP encompasses hormonal contraceptives among a broader portfolio of generic medications and serves participating state and local government facilities across Minnesota and Oregon. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC), certify cGMP and DSCSA compliance, carry comprehensive insurance including $5 million commercial general liability and $2 million network security liability, and submit pricing in fixed, net-price, or WAC-minus formats. Awarded vendors will be effective July 1, 2026, and the contract term runs two years for new responders with optional extensions, while incumbent responders' amendments extend through June 30, 2028. Price competitiveness weighted at 75 percent of evaluation, with administrative fees of 3 percent applied to all purchases and performance penalties ranging from $200 to $1,500 per violation.